Sarepta Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Sarepta Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Sarepta Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $884M, a 8.84% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $884M +$71.8M +8.84% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $812M +$140M +20.8% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $672M +$66.5M +11% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $606M +$117M +23.9% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $489M +$119M +32.4% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $369M +$165M +80.5% Dec 31, 2018 10-K 2020-02-26
Q4 2017 $205M -$69.5M -25.4% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $274M +$54.3M +24.7% Dec 31, 2016 10-K 2018-03-01
Q4 2015 $220M +$54.1M +32.6% Dec 31, 2015 10-K 2017-02-28
Q4 2014 $166M +$32.2M +24.1% Dec 31, 2014 10-K 2016-02-25
Q4 2013 $134M +$19.4M +17% Dec 31, 2013 10-K 2015-02-26
Q4 2012 $114M -$2.68M -2.3% Dec 31, 2012 10-K 2014-03-03
Q4 2011 $117M Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.